| Line Item | 2025-04-25 | Y/Y |
|---|---|---|
| Revenue | $6.57B | +16.2% |
| Cost of Revenue | $1.96B | +6.8% |
| Gross Profit | $4.61B | +4.1% |
| R&D Expense | $1.01B | -1.7% |
| SG&A Expense | $311.0M | +1.0% |
| Operating Income | $1.34B | +10.1% |
| Pre-tax Income | $1.38B | +9.5% |
| Income Tax | $197.0M | -28.9% |
| Net Income | $1.19B |
| Line Item | 2025-04-25 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.74B | +44.1% |
| Short-term Investments | $1.10B | -18.2% |
| Accounts Receivable | $1.25B | +23.7% |
| Inventory | $186.0M | +0.0% |
| Current Assets | $5.85B | +19.5% |
| Total Assets | $10.82B | +9.5% |
| Current Liabilities | $4.66B | +13.5% |
| Line Item | 2025-04-25 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.51B | -10.6% |
| Capital Expenditures | $168.0M | +8.4% |
| Investing Cash Flow | $147.0M | +120.0% |
| Financing Cash Flow | -$828.0M | +38.4% |
| Free Cash Flow | $1.34B | -12.5% |
| +20.3% |
| EPS (Basic) | $5.81 | +22.6% |
| EPS (Diluted) | $5.67 | +22.5% |
| Long-term Debt |
| $3.23B |
| +35.2% |
| Total Liabilities | $9.78B | +11.9% |
| Stockholders' Equity | $1.04B | -9.2% |